Feb 23 (Reuters) - Cyclopharm:
- FY SALES REVENUE OF A$17.70 MILLION, UP 20.6%
- FINAL DIVIDEND MAINTAINED AT 0.5 AU CENTS PER SHARE
- REVENUE FROM TECHNEGAS GENERATOR & PAS SALES IS EXPECTED TO CONTINUE TO REBOUND TO PRE‐PANDEMIC LEVELS OR BEYOND IN 2022
News: CYC Cyclopharm Posts FY Sales Revenue Of A$17.70 Million
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.37 |
Change
-0.010(0.72%) |
Mkt cap ! $152.2M | |||
| Open | High | Low | Value | Volume |
| $1.36 | $1.39 | $1.36 | $33.14K | 24.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2870 | $1.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.38 | 6918 | 1 |
View Market Depth
| Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
| CYC (ASX) Chart |